Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02033083 · ClinicalTrials.gov registry record · NA

Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation

A NA study of Second Trimester Abortion, sponsored by Planned Parenthood of Greater New York.

Completed
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT02033083 is a NA study of Second Trimester Abortion that has completed, run by Planned Parenthood of Greater New York. The registered enrollment target is 180 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02033083, a NA study of Second Trimester Abortion, has completed, sponsored by Planned Parenthood of Greater New York.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

Primary objective: To study the difference in dilation and evacuation (D\&E) procedure time following overnight cervical preparation with laminaria or Dilapan-S™. The investigators hypothesize procedure time will be less with Dilapan-S™. Secondary objectives: To compare the use of laminaria and Dilapan-S™ for differences in: (1) initial cervical dilation before D\&E; (2) need for mechanical dilation to accomplish D\&E and ease of dilation if required; (3) number of osmotic dilators placed; (4) ability to complete the D\&E procedure without further cervical preparation; (5) complications; (6) pain and other side effects; (7) patient acceptability; and (8) provider acceptability.

Conditions Studied

Interventions

  • DEVICE Dilapan-S
  • DEVICE Laminaria

Study Locations (1)

New York

  • Planned Parenthood of New York City - New York

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2013-12
Est. Completion 2016-02
Phase NA

What the Registry Record Tells You About NCT02033083

The ClinicalTrials.gov registry entry for NCT02033083 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood of Greater New York, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Second Trimester Abortion appearing as the primary indexed condition, and to 2 interventions - of which Dilapan-S is the first listed.

NCT02033083 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02033083 about?

NCT02033083 is a clinical study titled "Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation". Primary objective: To study the difference in dilation and evacuation (D\&E) procedure time following overnight cervical preparation with laminaria or Dilapan-S™. The investigators hypothesize procedure time will be less with Dilapan-S™. Secondary objectives: To compare the use of laminaria and Dil...

What is the current status of trial NCT02033083?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2013-12. Estimated completion is 2016-02.

What conditions does trial NCT02033083 study?

This clinical trial studies the following conditions: Second Trimester Abortion.

What interventions are being tested in trial NCT02033083?

The interventions under investigation include: Dilapan-S (DEVICE), Laminaria (DEVICE).

Who is sponsoring clinical trial NCT02033083?

This trial is sponsored by Planned Parenthood of Greater New York, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02033083 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Second Trimester Abortion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.